HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER


[Advanced]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Castillo, J C
Right arrow Articles by Vallés, F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Castillo, J C
Right arrow Articles by Vallés, F
Heart 2000;83:525-530 ( May )

Cardiovascular medicine

Long term outcome of infective endocarditis in patients who were not drug addicts: a 10 year study J C Castillo, M P Anguita, A Ramírez, J R Siles, F Torres, D Mesa, M Franco, I Muñoz, M Concha, F Vallés

Servicio de Cardiología, Hospital Universitario Reina Sofía, Córdoba, Avda Menéndez Pidal, s/n 14004 Cordoba, Spain

Correspondence to: Dr Castillo

Accepted 18 January 2000

OBJECTIVE---To determine the clinical features and long term prognosis of infective endocarditis in patients who were not drug addicts.
DESIGN---Prospective case series.
SETTING---A university hospital that is both a referral and a primary care centre.
PATIENTS---138 consecutive cases of infective endocarditis diagnosed and treated from January 1987 to March 1997.
RESULTS---Mean patient age was 44 (20) years old. 95 patients (69%) had native valve endocarditis and 43 (31%) had prosthetic valve endocarditis. Staphylococci were the causal microorganisms in 34% of cases and streptococci in 33%. Severe complications occurred in 83% of patients and 51% of patients underwent surgery during the active phase (22% was emergency surgery). Inpatient mortality was 21%. During a follow up of 56 (44) months, 10 patients (9%) needed late cardiac surgery and seven (5% of the whole series) died. Overall 10 year survival was 71%. There were no significant differences in survival depending on the type of treatment received during the hospital stay (medical or combined medical-surgical).
CONCLUSIONS---A high early surgery rate is related to good long term results and does not increase in-hospital mortality. Medical treatment, however, also offers favourable long term results in cases of responsive infective endocarditis where poor prognostic factors are absent.


Keywords: infective endocarditis; staphylococci; streptococci

© 2000 by Heart


This article has been cited by other articles:


Home page
 HeartHome page
G Doukas, M Oc, C Alexiou, A W Sosnowski, N J Samani, and T J Spyt
Mitral valve repair for active culture positive infective endocarditis
Heart, March 1, 2006; 92(3): 361 - 363.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
P Tornos, B Iung, G Permanyer-Miralda, G Baron, F Delahaye, C. Gohlke-Barwolf, E G Butchart, P Ravaud, and A Vahanian
Infective endocarditis in Europe: lessons from the Euro heart survey
Heart, May 1, 2005; 91(5): 571 - 575.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
T. S. J. Elliott, J. Foweraker, F. K. Gould, J. D. Perry, and J. A. T. Sandoe
Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy
J. Antimicrob. Chemother., December 1, 2004; 54(6): 971 - 981.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
S. Homma and C. Grahame-Clarke
Reply
J. Am. Coll. Cardiol., March 17, 2004; 43(6): 1134 - 1134.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
B. Iung, J. Rousseau-Paziaud, B. Cormier, E. Garbarz, O. Fondard, E. Brochet, C. Acar, J.-P. Couetil, U. Hvass, and A. Vahanian
Contemporary results of mitral valve repair for infective endocarditis
J. Am. Coll. Cardiol., February 4, 2004; 43(3): 386 - 392.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
B. Piechowski-Jozwiak and J. Bogousslavsky
Infectious endocarditis and stroke: Any lessons learned since William Osler's Gulstonian lectures?
Neurology, November 25, 2003; 61(10): 1324 - 1325.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
K.-L. Chan, J. G. Dumesnil, B. Cujec, A. J. Sanfilippo, J. Jue, M. A. Turek, T. I. Robinson, D. Moher, and Investigators of the Multicenter Aspirin Study in
A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis
J. Am. Coll. Cardiol., September 3, 2003; 42(5): 775 - 780.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
S. Homma and C. Grahame-Clarke
Toward reducing embolic complications from endocarditis
J. Am. Coll. Cardiol., September 3, 2003; 42(5): 781 - 783.
[Full Text] [PDF]

Home page
 HeartHome page
R O M Netzer, S C Altwegg, E Zollinger, M Tauber, T Carrel, and C Seiler
Infective endocarditis: determinants of long term outcome
Heart, July 1, 2002; 88(1): 61 - 66.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
J M Guerra, M P Tornos, G Permanyer-Miralda, B Almirante, M Murtra, and J Soler-Soler
Long term results of mechanical prostheses for treatment of active infective endocarditis
Heart, July 1, 2001; 86(1): 63 - 68.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2000 BMJ Publishing Group Ltd & British Cardiovascular Society